Paradigm Biopharmaceuticals Limited (PAR.AX)
AUD 0.32
(3.23%)
AUD 0.32
(3.23%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 3.58 Million AUD | -73.23% |
| 2023 | 13.39 Million AUD | 59.88% |
| 2022 | 8.37 Million AUD | 28.49% |
| 2021 | 6.51 Million AUD | 55.88% |
| 2020 | 4.18 Million AUD | 54.62% |
| 2019 | 2.7 Million AUD | 103.8% |
| 2018 | 1.32 Million AUD | 38.92% |
| 2017 | 955.28 Thousand AUD | -14.45% |
| 2016 | 1.11 Million AUD | 93.42% |
| 2015 | 577.32 Thousand AUD | 56.6% |
| 2014 | 368.66 Thousand AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 11.23 Million AUD | 0.0% |
| 2024 FY | 3.58 Million AUD | -73.23% |
| 2024 Q4 | 3.58 Million AUD | 0.0% |
| 2023 FY | 13.39 Million AUD | 59.88% |
| 2023 Q4 | 13.39 Million AUD | 0.0% |
| 2023 Q2 | 14.83 Million AUD | 0.0% |
| 2022 Q4 | 8.37 Million AUD | 0.0% |
| 2022 Q2 | 14.57 Million AUD | 0.0% |
| 2022 FY | 8.37 Million AUD | 28.49% |
| 2021 FY | 6.51 Million AUD | 55.88% |
| 2021 Q4 | 6.51 Million AUD | 0.0% |
| 2021 Q2 | 5.83 Million AUD | 0.0% |
| 2020 Q4 | 4.18 Million AUD | 0.0% |
| 2020 FY | 4.18 Million AUD | 54.62% |
| 2020 Q2 | 1.97 Million AUD | 0.0% |
| 2019 Q4 | 2.7 Million AUD | 0.0% |
| 2019 FY | 2.7 Million AUD | 103.8% |
| 2019 Q2 | 1.15 Million AUD | 0.0% |
| 2018 Q2 | 1.36 Million AUD | 0.0% |
| 2018 FY | 1.32 Million AUD | 38.92% |
| 2018 Q4 | 1.32 Million AUD | 0.0% |
| 2017 Q2 | 1.63 Million AUD | 0.0% |
| 2017 Q4 | 955.28 Thousand AUD | 0.0% |
| 2017 FY | 955.28 Thousand AUD | -14.45% |
| 2016 Q2 | 420.25 Thousand AUD | 0.0% |
| 2016 Q4 | 1.11 Million AUD | 0.0% |
| 2016 FY | 1.11 Million AUD | 93.42% |
| 2015 Q4 | 585.28 Thousand AUD | 0.0% |
| 2015 FY | 577.32 Thousand AUD | 56.6% |
| 2014 FY | 368.66 Thousand AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AdAlta Limited | 3.54 Million AUD | -1.18% |
| Acrux Limited | 5.68 Million AUD | 36.973% |
| Race Oncology Limited | 1.91 Million AUD | -87.033% |
| Biome Australia Limited | 5.37 Million AUD | 33.293% |
| Botanix Pharmaceuticals Limited | 3.73 Million AUD | 3.959% |
| BTC Health Limited | 203.94 Thousand AUD | -1657.478% |
| Chimeric Therapeutics Limited | 12.8 Million AUD | 72.004% |
| CSL Limited | 27.88 Billion AUD | 99.987% |
| Clarity Pharmaceuticals Ltd | 8.33 Million AUD | 56.98% |
| Clinuvel Pharmaceuticals Limited | 28.11 Million AUD | 87.25% |
| EZZ Life Science Holdings Limited | 4.22 Million AUD | 15.247% |
| Hexima Limited | 248.67 Thousand AUD | -1341.405% |
| Immutep Limited | 10.97 Million AUD | 67.355% |
| Memphasys Limited | 5.59 Million AUD | 35.907% |
| Neuren Pharmaceuticals Limited | 42.76 Million AUD | 91.618% |
| Noxopharm Limited | 1.28 Million AUD | -178.155% |
| Prescient Therapeutics Limited | 2.32 Million AUD | -54.128% |
| Radiopharm Theranostics Limited | 44.68 Million AUD | 91.978% |
| Starpharma Holdings Limited | 8.69 Million AUD | 58.791% |
| Tissue Repair Ltd | 1.35 Million AUD | -165.329% |
| Biotron Limited | 737.5 Thousand AUD | -386.007% |
| Alterity Therapeutics Limited | 5.42 Million AUD | 33.938% |
| Anatara Lifesciences Ltd | 306.84 Thousand AUD | -1068.112% |
| Bio-Gene Technology Limited | 368.44 Thousand AUD | -872.827% |
| Zelira Therapeutics Limited | 9.35 Million AUD | 61.692% |
| Patrys Limited | 691.36 Thousand AUD | -418.444% |
| Orthocell Limited | 22.08 Million AUD | 83.769% |
| Imugene Limited | 33.14 Million AUD | 89.185% |
| PYC Therapeutics Limited | 10.18 Million AUD | 64.805% |
| Proteomics International Laboratories Limited | 1.62 Million AUD | -120.449% |
| Cynata Therapeutics Limited | 1.17 Million AUD | -206.078% |
| Arovella Therapeutics Limited | 2.05 Million AUD | -74.282% |
| Nanollose Limited | 465.64 Thousand AUD | -669.762% |
| Invex Therapeutics Ltd | 431.63 Thousand AUD | -730.42% |
| NeuroScientific Biopharmaceuticals Limited | 85.68 Thousand AUD | -4083.258% |
| Amplia Therapeutics Limited | 3.42 Million AUD | -4.597% |
| Island Pharmaceuticals Limited | 1.04 Million AUD | -242.794% |
| Nyrada Inc. | 855.63 Thousand AUD | -318.911% |
| Telix Pharmaceuticals Limited | 249.39 Million AUD | 98.563% |
| Dimerix Limited | 13.89 Million AUD | 74.2% |
| PharmAust Limited | 896.6 Thousand AUD | -299.767% |
| AnteoTech Limited | 4.07 Million AUD | 12.046% |
| Recce Pharmaceuticals Ltd | 15.89 Million AUD | 77.448% |
| Avecho Biotechnology Limited | 941.54 Thousand AUD | -280.689% |
| Actinogen Medical Limited | 1.61 Million AUD | -121.89% |
| Immuron Limited | 2.84 Million AUD | -26.186% |
| Argenica Therapeutics Limited | 2.42 Million AUD | -47.703% |